The CCR2-64I polymorphism, which slightly impairs capacity to transduce CCL2 signals, is underrepresented in patients with breast cancer [17, 57], and this might provide protection from tumour formation through reduced recruitment of tumour-promoting macrophages. The gene discussed is CCL2; the disease is breast cancer.